Karin Tegerstedt

692 total citations
13 papers, 510 citations indexed

About

Karin Tegerstedt is a scholar working on Oncology, Molecular Biology and Animal Science and Zoology. According to data from OpenAlex, Karin Tegerstedt has authored 13 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Animal Science and Zoology. Recurrent topics in Karin Tegerstedt's work include Polyomavirus and related diseases (9 papers), Virus-based gene therapy research (4 papers) and Animal Virus Infections Studies (4 papers). Karin Tegerstedt is often cited by papers focused on Polyomavirus and related diseases (9 papers), Virus-based gene therapy research (4 papers) and Animal Virus Infections Studies (4 papers). Karin Tegerstedt collaborates with scholars based in Sweden, Italy and United States. Karin Tegerstedt's co-authors include Tina Dalianis, Torbjörn Ramqvist, Kalle Andreasson, Pär Gellerfors, Lars Lannfelt, Linda Söderberg, Hanna Laudon, Anna Lord, Charlotte Sahlin and Johan Sjödahl and has published in prestigious journals such as PLoS ONE, Cancer Research and International Journal of Cancer.

In The Last Decade

Karin Tegerstedt

13 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin Tegerstedt Sweden 11 228 154 124 101 87 13 510
Patricia Bach Germany 9 254 1.1× 243 1.6× 134 1.1× 129 1.3× 62 0.7× 11 613
Chizuko Takamura Japan 11 313 1.4× 212 1.4× 28 0.2× 52 0.5× 18 0.2× 12 621
Florian Brod United Kingdom 10 156 0.7× 198 1.3× 23 0.2× 45 0.4× 59 0.7× 11 439
Yun‐Zhou Yu China 14 99 0.4× 195 1.3× 19 0.2× 38 0.4× 154 1.8× 73 649
Lauren Gravitz Canada 11 64 0.3× 158 1.0× 49 0.4× 46 0.5× 40 0.5× 28 498
Nobutaka Matsumura Japan 6 135 0.6× 502 3.3× 39 0.3× 38 0.4× 33 0.4× 9 678
W.L. Karshin United States 11 400 1.8× 448 2.9× 37 0.3× 64 0.6× 185 2.1× 13 1.1k
Ute Woehlbier Chile 17 88 0.4× 395 2.6× 30 0.2× 24 0.2× 181 2.1× 28 1.1k
Pam Witte United States 6 40 0.2× 501 3.3× 73 0.6× 178 1.8× 141 1.6× 7 840
Martha S. Vokes United States 9 89 0.4× 351 2.3× 39 0.3× 18 0.2× 45 0.5× 10 659

Countries citing papers authored by Karin Tegerstedt

Since Specialization
Citations

This map shows the geographic impact of Karin Tegerstedt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Tegerstedt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Tegerstedt more than expected).

Fields of papers citing papers by Karin Tegerstedt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Tegerstedt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Tegerstedt. The network helps show where Karin Tegerstedt may publish in the future.

Co-authorship network of co-authors of Karin Tegerstedt

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Tegerstedt. A scholar is included among the top collaborators of Karin Tegerstedt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Tegerstedt. Karin Tegerstedt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Tucker, Stina, Christer Möller, Karin Tegerstedt, et al.. (2014). The Murine Version of BAN2401 (mAb158) Selectively Reduces Amyloid-β Protofibrils in Brain and Cerebrospinal Fluid of tg-ArcSwe Mice. Journal of Alzheimer s Disease. 43(2). 575–588. 200 indexed citations
2.
Knudsen, Maria L., Daniel X. Johansson, Eva Nordström, et al.. (2013). The Adjuvant Activity of Alphavirus Replicons Is Enhanced by Incorporating the Microbial Molecule Flagellin into the Replicon. PLoS ONE. 8(6). e65964–e65964. 11 indexed citations
3.
Magnusson, Kristina, Dag Sehlin, Stina Syvänen, et al.. (2013). Specific Uptake of an Amyloid-β Protofibril-Binding Antibody-Tracer in AβPP Transgenic Mouse Brain. Journal of Alzheimer s Disease. 37(1). 29–40. 75 indexed citations
4.
Andreasson, Kalle, et al.. (2011). Murine Polyomavirus Virus-Like Particles Carrying Full-Length Human PSA Protect BALB/c Mice from Outgrowth of a PSA Expressing Tumor. PLoS ONE. 6(8). e23828–e23828. 24 indexed citations
5.
6.
Andreasson, Kalle, Karin Tegerstedt, Claudia Curcio, et al.. (2008). Murine pneumotropic virus chimeric Her2/neu virus‐like particles as prophylactic and therapeutic vaccines against Her2/neu expressing tumors. International Journal of Cancer. 124(1). 150–156. 25 indexed citations
7.
Tegerstedt, Karin, et al.. (2007). Dendritic cells loaded with polyomavirus VP1/VP2Her2 virus-like particles efficiently prevent outgrowth of a Her2/neu expressing tumor. Cancer Immunology Immunotherapy. 56(9). 1335–1344. 29 indexed citations
8.
Tegerstedt, Karin, Claudia Curcio, Kalle Andreasson, et al.. (2005). A Single Vaccination with Polyomavirus VP1/VP2Her2 Virus-Like Particles Prevents Outgrowth of HER-2/neu–Expressing Tumors. Cancer Research. 65(13). 5953–5957. 57 indexed citations
9.
Tegerstedt, Karin, et al.. (2005). Murine polyomavirus-VP1 virus-like particles immunize against some polyomavirus-induced tumours.. PubMed. 19(2). 323–6. 8 indexed citations
10.
Tegerstedt, Karin, Kalle Andreasson, Jeanna Joneberg, et al.. (2005). Murine polyomavirus virus-like particles (VLPs) as vectors for gene and immune therapy and vaccines against viral infections and cancer.. PubMed. 25(4). 2601–8. 19 indexed citations
11.
Rollman, Erik, Torbjörn Ramqvist, Bartek Zuber, et al.. (2003). Genetic immunization is augmented by murine polyomavirus VP1 pseudocapsids. Vaccine. 21(19-20). 2263–2267. 6 indexed citations
12.
13.
Vlastos, Andrea, Kalle Andreasson, Karin Tegerstedt, et al.. (2003). VP1 pseudocapsids, but not a glutathione‐S‐transferase VP1 fusion protein, prevent polyomavirus infection in a T‐cell immune deficient experimental mouse model. Journal of Medical Virology. 70(2). 293–300. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patricia Bach Breakdown of academic impact, for papers by Chizuko Takamura Breakdown of academic impact, for papers by Florian Brod Breakdown of academic impact, for papers by Yun‐Zhou Yu Breakdown of academic impact, for papers by Lauren Gravitz Breakdown of academic impact, for papers by Nobutaka Matsumura Breakdown of academic impact, for papers by W.L. Karshin Breakdown of academic impact, for papers by Ute Woehlbier Breakdown of academic impact, for papers by Pam Witte Breakdown of academic impact, for papers by Martha S. Vokes
Rankless by CCL
2026